Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M. Goldman

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
International Journal of Hematology|November 15, 2002
Treatment of chronic myeloid leukaemia: lessons and challengesJohn M Goldman
Hematology. American Society of Hematology. Education Program|December 17, 2009
Initial treatment for patients with CMLJohn M Goldman
Best Practice & Research. Clinical Haematology|December 5, 2009
Treatment strategies for CMLJohn M Goldman
Seminars in Hematology|April 12, 2003
Therapeutic strategies for chronic myeloid leukemia in the chronic (stable) phaseJohn M Goldman
Hematology/Oncology Clinics of North America|October 17, 2003
Myeloproliferative and myelodysplastic syndromes: the futureJohn M Goldman
Blood|July 14, 2007
How I treat chronic myeloid leukemia in the imatinib eraJohn M Goldman
Seminars in Hematology|September 30, 2010
Chronic myeloid leukemia: a historical perspectiveJohn M Goldman
Experimental Hematology|January 17, 2004
Chronic myeloid leukemia-still a few questionsJohn M Goldman
Seminars in Hematology|February 4, 2003
Management decisions in chronic myeloid leukemiaJohn M Goldman, David Marin
Oncology (Williston Park, N.Y.)|November 27, 2012
Is imatinib still an acceptable first-line treatment for CML in chronic phase?John M Goldman, David Marin
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
International Journal of Hematology|November 15, 2002
Treatment of chronic myeloid leukaemia: lessons and challengesJohn M Goldman
Hematology. American Society of Hematology. Education Program|December 17, 2009
Initial treatment for patients with CMLJohn M Goldman
Best Practice & Research. Clinical Haematology|December 5, 2009
Treatment strategies for CMLJohn M Goldman
Seminars in Hematology|April 12, 2003
Therapeutic strategies for chronic myeloid leukemia in the chronic (stable) phaseJohn M Goldman
Hematology/Oncology Clinics of North America|October 17, 2003
Myeloproliferative and myelodysplastic syndromes: the futureJohn M Goldman
Blood|July 14, 2007
How I treat chronic myeloid leukemia in the imatinib eraJohn M Goldman
Seminars in Hematology|September 30, 2010
Chronic myeloid leukemia: a historical perspectiveJohn M Goldman
Experimental Hematology|January 17, 2004
Chronic myeloid leukemia-still a few questionsJohn M Goldman
Seminars in Hematology|February 4, 2003
Management decisions in chronic myeloid leukemiaJohn M Goldman, David Marin
Oncology (Williston Park, N.Y.)|November 27, 2012
Is imatinib still an acceptable first-line treatment for CML in chronic phase?John M Goldman, David Marin
Pageof 10